Finnrick - Ensuring a Safer and More Transparent Supply Chain
TSC Top Supplements China

TSC Top Supplements China
Tirzepatide

Finnrick tested 5 samples of Tirzepatide (GLP-1 and GIP antagonist) from TSC Top Supplements China between 3 Jun 2025 and 4 Sep 2025. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).

Finnrick Rating™
B
GOOD
Tentative Rating
TSC Top Supplements China
Tirzepatide
Tested 5 Samples
Last test 4 Sep 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from TSC Top Supplements China

Samples are tested in commercial labs

Tests Count

5

Scores

AVG6.8MIN5.7MAX8.0

Last

4 Sep 2025

First

3 Jun 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
4 Sep 2025View8.030mg30.800mg+2.7%99.95%(no batch ID)No Label / Silver Crimp / Green Cap Lab EPublic
1 Sep 2025View5.810mg10.840mg+8.4%99.43%(no batch ID)No Label / Silver Crimp / Red Cap Lab FPublic
16 Jul 2025View8.030mg30.600mg+2.0%99.90%(no batch ID)No Label / Silver Crimp / Black CapLab EPublic
9 Jul 2025View6.530mg32.010mg+6.7%99.53%(no batch ID)No Label / Silver Crimp / Black CapLab APublic
3 Jun 2025View5.710mg8.600mg-14.0%99.86%(no batch ID)No Label / Silver Crimp / Black CapLab EPublic